Phio Pharmaceuticals Corp. logo
Phio Pharmaceuticals Corp. PHIO
$ 1.73 -0.57%

Квартальный отчет 2024-Q3
добавлен 14.11.2024

report update icon

Phio Pharmaceuticals Corp. Мультипликаторы 2011-2024 | PHIO

Мультипликаторы по годам Phio Pharmaceuticals Corp.

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-0.1 -0.6 -0.1 -2.1 -0.5 -0.3 -0.8 -0.5 -1.5 -2.3 -2.4 - -

P/S

- - - 4147.8 194.0 18.2 624.6 230.1 442.9 283.5 125.8 - -

EPS

-5.2 -10.1 -12.4 -1.9 -19.3 -57.5 -5.5 -16.4 -2.1 -0.8 -2.9 -5.6 -0.3

EV (Enterprise Value)

-5.46 млн -3.16 млн -19.9 млн 6.57 млн -569 тыс. -10.6 млн 8.05 млн -5.99 млн 12.2 млн 18.1 млн 48.8 млн 6.3 млн 1.78 млн

EBITDA per Share

-5.17 -10 -12.6 -1.51 -19.4 -56.9 -226 -731 -1.12 тыс. -2.94 тыс. -11.2 тыс. - -

EV/EBITDA

1.5 -0.5 0.3 1.7 -0.6 1.0 -1.0 -1.3 -1.9 0.4 -

PEG

-0.0 -0.01 -0.0 -1.62 -0.01 -0.0 -0.01 -0.02 -0.02 -0.03 -0.06 - -

P/B

0.2 0.6 0.0 1.4 0.7 0.2 5.1 0.4 1.7 7.3 10.2 - -

P/CF

-0.1 -0.5 -0.1 -2.1 -0.5 -0.3 -1.0 -0.6 -2.0 -2.6 -7.9 - -

ROE %

-140.05 -105.92 -60.58 -67.56 -154.98 -54.21 -679.32 -82.86 -114.99 -320.58 -423.41 -331.11 -

ROA %

-115.61 -89.59 -52.79 -55.87 -110.81 -48.04 -303.86 -67.13 -91.61 -95.77 -140.08 -230.41 -

ROCE %

-140.03 -105.76 -61.60 -64.93 -145.92 -54.23 -510.97 -83.05 -115.15 -112.36 -162.88 -329.41 -

Current Ratio

5.7 6.5 7.8 6.9 3.9 8.7 1.7 5.2 4.8 6.7 7.1 3.2 -

DSO

- - - - - - - - - - - - -

DIO

- - - - - - - - - - - - -

DPO

- - - - - - - - - - - - -

Операционный цикл

- - - - - - - - - - - - -

Финансовый цикл

- - - - - - - - - - - - -

Все данные представлены в валюте USD

Мультипликаторы поквартально Phio Pharmaceuticals Corp.

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-1.54 -3.62 -0.47 - -10.25 -13.27 -3.15 - -3.14 -2.22 -2.34 - -0.28 -0.2 -0.32 - -0.4 -0.34 -1.33 - -4.53 -4.62 -5.71 - -0.34 -0.46 -0.9 - -1.05 -1.12 -2.65 - -3.36 -3.38 -3.41 - -0.38 -0.5 -1.32 - -0.17 -0.23 -0.32 - -0.3 -0.39 -2.76 - -0.56 -4.13 -0.04 - -0.05 -0.05 -

EBITDA per Share

- - -0.48 - - - -3.14 - -3.09 - -2.32 - -0.27 -0.2 -0.34 - -0.39 -0.33 -1.32 - -4.46 -4.59 -5.73 - -0.33 -0.45 -0.89 - -1.03 -1.11 -3.44 - -3.31 -3.35 -3.41 - -0.38 -0.48 -1.23 - -0.12 -0.14 -0.18 - -0.17 -0.17 -2.21 - -0.3 -1.72 - - -0.05 - -

ROE %

-156.72 -164.45 -141.26 -113.55 -139.98 -127.88 -117.03 -54.90 -69.73 -58.11 -52.54 -34.99 -52.73 -55.64 -59.17 -48.64 -85.07 -103.77 -126.32 -108.70 -119.69 -94.26 -72.86 -41.49 -176.57 -300.65 -423.80 -570.10 -590.48 -475.78 -359.01 -61.31 -89.38 -97.08 -101.07 -85.57 -165.93 -218.22 -266.93 -236.65 -278.31 -239.61 -206.21 -372.66 -344.51 -274.70 -14.47 469.25 901.44 1305.49 1517.14 - 432.20 432.20 -

ROA %

-121.42 -124.58 -110.45 -86.98 -109.63 -103.13 -94.96 -47.13 -60.52 -51.27 -47.19 -31.94 -46.61 -47.89 -50.03 -40.23 -66.28 -77.66 -92.35 -77.72 -87.47 -71.16 -58.25 -36.76 -97.18 -147.86 -196.80 -255.00 -271.51 -227.61 -182.77 -49.68 -72.04 -77.90 -80.80 -68.17 -92.18 -93.82 -96.24 -70.69 -84.48 -74.25 -65.55 -123.29 -152.69 -168.30 -385.51 -490.06 -639.82 -760.19 -679.62 - -149.76 -149.76 -

ROCE %

-160.78 -167.12 -142.11 -113.47 -139.87 -127.78 -116.89 -54.80 -69.61 -58.02 -52.50 -35.70 -53.42 -56.32 -59.84 -48.64 -85.40 -104.44 -127.44 -109.92 -120.90 -95.13 -73.30 -41.46 -176.54 -300.63 -423.80 -658.54 -678.95 -564.29 -447.54 -61.50 -89.67 -97.42 -101.37 -85.66 -166.13 -218.44 -267.71 -237.52 -279.43 -240.86 -207.00 -372.93 -343.88 -272.94 -101.96 192.88 562.04 902.17 770.95 - 369.17 - -

Current Ratio

- - - - 4.1 5.1 4.0 6.5 7.0 6.4 8.2 7.8 10.4 11.3 13.8 5.8 5.8 5.8 5.8 3.5 3.5 3.5 3.5 8.8 8.8 8.8 8.8 - - - - - - - - - - - - - - - - 7.2 11.1 9.9 7.6 3.3 3.3 3.3 3.3 0.7 0.7 0.7 0.7

DSO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Операционный цикл

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Финансовый цикл

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Все данные представлены в валюте USD